Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

PR NewswireSep 9 09:29 ET

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes

PR NewswireSep 4 09:29 ET

Genprex to Present and Participate at Upcoming September Investor and Industry Conferences

PR NewswireSep 3 08:15 ET

Express News | Genprex CMO Reports Clincal Study Updates From Acclaim-1 And Acclaim-3 Phase 1/2 Clinical Trials In Lung Cancer

BenzingaAug 15 09:37 ET

Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials

GenprexAug 15 00:00 ET

Express News | Genprex Shares Are Trading Lower. The Company Announced Updates From Its Acclaim-1 and Acclaim-3 Phase 1/2 Clinical Trials for Lung Cancer and Ceased Enrollment in Its Acclaim-2 Clinical Trial Due to Patient Recruitment Difficulties

BenzingaAug 14 15:18 ET